Found: 17
Select item for more details and to access through your institution.
Some patients with glioblastoma may benefit from epidermal growth factor receptor inhibition.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4175, doi. 10.1002/cncr.34547
- Publication type:
- Article
New assay for early detection of hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4176, doi. 10.1002/cncr.34548
- Publication type:
- Article
Molecular insights into triple-negative breast cancer metastasis: Epithelial- mesenchymal transition: There is a need to better understand the molecular drivers behind triple-negative breast cancer to help curb the incidence of metastasis: There is a need to better understand the molecular drivers behind triple-negative breast cancer to help curb the incidence of metastasis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4174, doi. 10.1002/cncr.34546
- By:
- Publication type:
- Article
Thank You to Reviewers 2022.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4296, doi. 10.1002/cncr.34516
- Publication type:
- Article
Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4194, doi. 10.1002/cncr.34502
- By:
- Publication type:
- Article
Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4213, doi. 10.1002/cncr.34495
- By:
- Publication type:
- Article
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4185, doi. 10.1002/cncr.34498
- By:
- Publication type:
- Article
Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4203, doi. 10.1002/cncr.34493
- By:
- Publication type:
- Article
What if the age at which a woman started regular mammographic screening depended on her risk, not age?
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4179, doi. 10.1002/cncr.34491
- By:
- Publication type:
- Article
What happens in the long term: Uptake of cancer surveillance and prevention strategies among at‐risk relatives with pathogenic variants detected via cascade testing.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4241, doi. 10.1002/cncr.34482
- By:
- Publication type:
- Article
Annual report to the nation on the status of cancer, part 1: National cancer statistics.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4251, doi. 10.1002/cncr.34479
- By:
- Publication type:
- Article
Straining under the echoes of the past.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4182, doi. 10.1002/cncr.34466
- By:
- Publication type:
- Article
Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: "Repeat and replicate".
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4177, doi. 10.1002/cncr.34465
- By:
- Publication type:
- Article
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4285, doi. 10.1002/cncr.34464
- By:
- Publication type:
- Article
A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4223, doi. 10.1002/cncr.34463
- By:
- Publication type:
- Article
Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4232, doi. 10.1002/cncr.34365
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4167, doi. 10.1002/cncr.33028
- Publication type:
- Article